000 | 01967 a2200505 4500 | ||
---|---|---|---|
005 | 20250516221931.0 | ||
264 | 0 | _c20161031 | |
008 | 201610s 0 0 eng d | ||
022 | _a1097-0347 | ||
024 | 7 |
_a10.1002/hed.23822 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAxelrod, Mark J | |
245 | 0 | 0 |
_aSynergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathways. _h[electronic resource] |
260 |
_bHead & neck _cDec 2015 |
||
300 |
_a1722-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCarbamates _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
650 | 0 | 4 | _aCell Culture Techniques |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aDasatinib _xadministration & dosage |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xdrug effects |
650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
650 | 0 | 4 |
_aReceptor, IGF Type 1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTriazines _xadministration & dosage |
700 | 1 | _aMendez, Rolando E | |
700 | 1 | _aKhalil, Ashraf | |
700 | 1 | _aLeimgruber, Stephanie S | |
700 | 1 | _aSharlow, Elizabeth R | |
700 | 1 | _aCapaldo, Brian | |
700 | 1 | _aConaway, Mark | |
700 | 1 | _aGioeli, Daniel G | |
700 | 1 | _aWeber, Michael J | |
700 | 1 | _aJameson, Mark J | |
773 | 0 |
_tHead & neck _gvol. 37 _gno. 12 _gp. 1722-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hed.23822 _zAvailable from publisher's website |
999 |
_c23973443 _d23973443 |